Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Nov 10, 2022, after the close
10-Q filed Nov 10, 2022, 41 days after period end · 0000320017-22-000102
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $0.00 | — | — | — |
| Net Income | -$37.38M | -$6.93M | -$5.33M | -$4.90M |
| EPS Diluted |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$7.88 |
| -$1.74 |
| -$0.29 |
| -$0.47 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
